Use of compounds of the general formula (I)
or a pharmaceutically usable salt thereof; wherein R
1
, R
2
, R
3
, R
4
, R
5
and X have the definitions elucidated in more detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.